Clinical Trials Directory

Trials / Completed

CompletedNCT00634491

Comparison Between Effect of Acetazolamide and NaHco3 in Prevention of Contrast Nephropathy

Effect of Acetazolamide in Prevention of Contrast Nephropathy

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
240 (actual)
Sponsor
Shiraz University of Medical Sciences · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is whether Acetazolamide is effective in prevention of contrast nephropathy

Detailed description

Contrast induced nephropathy is one of common causes of acute renal failure many preventive protocol existed . 240 patient that underwent coronary angiography randomly divided in three groups.Group 1,2,3 will receive Bicarbonate ,Acetazolamide+Normal salin and Normal salin respectively.We compare prevalence of contrast nephropathy in each group.

Conditions

Interventions

TypeNameDescription
DRUGsodium bicarbonate150 meq/l Sodium bicarbonate 3cc/kg/hr before and 1cc/kg/hr after angiography
DRUGAcetazolamideAcetazolamide 250 mg+ 1 cc/kg/hr normal salin before and after angiography
DRUGnormal salin1 cc/kg/hr 6 hour before and after angiography

Timeline

Start date
2007-09-01
Primary completion
2008-02-01
Completion
2008-02-01
First posted
2008-03-13
Last updated
2008-03-13

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT00634491. Inclusion in this directory is not an endorsement.